path4143-sup-0001-Appendix S1.docWord document19162KAppendix S1. Supplementary materials and methods
path4143-sup-0002-Table S1.docWord document72K Table S1. Summary of the results obtained in different studies that assessed the invasion role of P-cadherin in several cell lines, taking into account the pattern of expression of classical cadherins (namely E- and N-cadherin).
path4143-sup-0003-Table S2.docWord document225K Table S2. Summary of the clinical, pathological, and immunohistochemical features of the studied series of 467 invasive breast carcinomas, including E- and P-cadherin expression.
path4143-sup-0004-Figure S1.docWord document220K Figure S1. Functional evaluation of E- and P-cadherin expression in SUM149 breast cancer cell line.
path4143-sup-0005-Figure S2.docWord document17520K Figure S2. Quantification of specific protein–protein interactions in breast cancer cells after E- and P-cadherin transcription silencing by specific siRNAs in SUM149.
path4143-sup-0006-Figure S3.docWord document466K Figure S3. BrdU proliferation assay.
path4143-sup-0007-Figure S4.docWord document362K Figure S4. Validation of microarray data of selected genes by qRT-PCR in SUM149 breast cancer cells.
path4143-sup-0008-Figure S5.docWord document391K Figure S5. Activity of Rac and Rho in BT20 breast cancer cells.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.